Lamisil Poses Serious Health Risks: Report
Novartis AG's oral fungal infection treatment Lamisil appears to put patients at risk of serious, and even life-threatening, liver, blood and skin problems, an Australian health regulator has reported....To view the full article, register now.
Already a subscriber? Click here to view full article